Viva Cyte Platfform Meddalwedd Swît gan Livia Stevenin

Mae Viva Cyte Platfform Meddalwedd Swît gan Livia Stevenin yn enillydd uchel ei barch o'r 2025 Gwobr Arian A' Design Award mawreddog iawn yng Nghategori Cystadleuaeth Rhyngwyneb.

ArianRhyngwyneb· 2025

Viva Cyte Platfform Meddalwedd Swît

gan Livia Stevenin

Cleient: Cellply

Enillydd Gwobr Arian A' Design Award yn y Categori Rhyngwyneb

56,621

Enillydd Gwobr Wedi'i Wirio

Gwirio Statws Gwobr ar gyfer #168358

Ymweld â'r Wefan Gweld yn A' Design Award Datganiad i'r Wasg Bathodyn Gwobr

Lliwiau

Y Dyluniad

Am Viva Cyte Platfform Meddalwedd Swît

Mae Viva Cyte yn blatfform meddalwedd datblygedig sydd wedi'i gynllunio i symleiddio datblygu therapi celloedd trwy integreiddio awtomeiddio, dadansoddiad trwybwn uchel, a phrofiad defnyddiwr greddfol. Mae'n cynnwys Meddalwedd Rheoli (CSW) ar gyfer rheoli profion biolegol a Meddalwedd Ddadansoddol (ASW) ar gyfer echdynnu mewnwelediadau ystyrlon. Mae awtomeiddio a yrrir gan AI yn lleihau gwall dynol, yn gwella cywirdeb, ac yn gwella defnyddioldeb, gan alluogi ymchwilwyr i lywio llif gwaith cymhleth yn effeithlon wrth gyflymu datblygiadau therapiwtig.

Y Gydnabyddiaeth

Am y Gwobr Arian A' Design Award

Mae Viva Cyte Platfform Meddalwedd Swît yn enillydd Gwobr Arian A' Design Award, cydnabyddiaeth hynod fawreddog a roddir i ddyluniadau o'r radd uchaf, hardd a thrawiadol. Mae enillwyr Arian yn weithiau tra disglair a hynod greadigol sydd yn darlunio arbenigedd, dawn a chraffter rhagorol eu dylunwyr. Disgwylir i Viva Cyte Platfform Meddalwedd Swît fod yn waith gwych ac esiampl, yn nodedig o broffesiynol ac yn ddwfn arloesol. Mae'r dyluniad buddugol hwn o Wobr Arian A' Design Award yn ddyfais hynod nodedig a edmygir sydd yn elwa ac yn symud ymlaen ffiniau celf, gwyddoniaeth, dylunio a thechnoleg. Mae Viva Cyte Platfform Meddalwedd Swît yn greadigaeth y cenfigennir wrthi yn eang, sydd yn deffro dyheadau, yn cyflwyno teimladau cadarnhaol ac yn cynnau rhyfeddod a syndod.

Y Tu Ôl i'r Dyluniad

Pecyn i'r Wasg

Credydau, aelodau tîm a manylion technegol a ddarparwyd gan y dylunydd.

Priodweddau Unigryw: The project focused on UX/UI design for two integrated software solutions: Control Software (CSW) for launching and managing biological tests and Analytical Software (ASW) for extracting key insights from results. The design prioritizes scalability, usability, and automation and enables researchers to navigate complex workflows, configure tests, and analyze data with minimal effort, streamlining the entire process.
Dimensiynau a Phecynnu: Design: Figma
Front-end: React JS
Design System: Bento
Tagiau: Cell therapy software, AI-driven automation, biomedical research, UX/UI design, data-driven, workflow optimization, healthcare innovation, regulatory compliance, user-centered design
Technoleg Cynhyrchu: We conducted extensive user research to design VivaCyte's software suite, including shadowing biologists in labs and interviewing end-users to understand their workflows and challenges. We also organized User Journey Mapping workshops, bringing together biologists and development teams to foster collaboration and gather diverse perspectives. The insights from these activities guided the creation of a custom design system, ensuring consistency and usability across the platforms.
Her Dylunio: Designing VivaCyte posed challenges in balancing usability, automation, and compliance. Internally, we had to align complex biological workflows with intuitive design, ensuring seamless lab adoption. Externally, strict medical regulations require adherence to compliance standards. Limited industry precedents and evolving AI capabilities pushed us to innovate with user research, iterative prototyping, and AI-driven automation, overcoming barriers in technology and regulatory constraints.
Ymchwil: We conducted user research to enhance VivaCyte’s usability and efficiency. Using shadowing and interviews, we observed lab workflows and identified pain points. Data was collected via on-site studies, journey mapping, and prototype testing with biologists and technicians. Insights led to features like printable maps and a guided setup walkthrough, reducing errors and improving efficiency. The research optimized workflows, accelerating cell therapy development.
Ysbrydoliaeth: Inspired by the need to accelerate cancer cell therapies, VivaCyte was designed to streamline workflows, reduce human error, and enhance patient care. Recognizing the challenges of complex, labour-intensive workflows in cell therapy development, we sought to create a solution that integrates advanced automation, high-throughput analysis, and intuitive design. The design prioritizes usability and scalability, enabling researchers and clinicians to focus on innovation rather than constraints.
Hyd y Prosiect: The project started in January 2022 in Milan and finished in August 2024.
Llif Gweithrediad: VivaCyte streamlines cell therapy workflows through an intuitive, automated interface. Users launch tests via the Control Software (CSW), which configures experiments that can be followed in real-time, while the Analytical Software (ASW) extracts biological insights and displays them. AI-driven automation minimizes errors, ensuring accuracy and efficiency. Designed for seamless interaction, it simplifies complex tasks, accelerates data analysis, and enhances usability.
Aelodau'r Tîm: Designer: Sara Bianchini
Designer: Livia Stevenin
Designer: Agnese Ragucci
Cydnabyddiaeth Delweddau: Image #1: Mockup: Designed by Freepik, Image: Livia Stevenin (UX/UI designer), Image #2: Livia Stevenin (UX/UI designer), Image #3: Livia Stevenin (UX/UI designer), Image #4: Livia Stevenin (UX/UI designer), Image #5: Livia Stevenin (UX/UI designer),